GCP
PHAS

GSA Capital Partners’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

GSA Capital Partners’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-186,031
Closed -$692K – 1897
2021
Q2 		$692K Sell
186,031
-24,625
-12% -$91.6K 0.08% 429
2021
Q1 		$729K Buy
210,656
+70,315
+50% +$243K 0.12% 201
2020
Q4 		$472K Sell
140,341
-13,975
-9% -$47K 0.08% 456
2020
Q3 		$542K Buy
+154,316
New +$542K 0.09% 345